Torben Larsen
Torben Larsen
Aalborg University
Bekræftet mail på dadlnet.dk - Startside
Titel
Citeret af
Citeret af
År
Updated European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist anticoagulants in patients with non-valvular atrial fibrillation
H Heidbuchel, P Verhamme, M Alings, M Antz, HC Diener, W Hacke, ...
Ep Europace 17 (10), 1467-1507, 2015
12152015
Efficacy and safety of dabigatran etexilate and warfarin in “real-world” patients with atrial fibrillation: a prospective nationwide cohort study
TB Larsen, LH Rasmussen, F Skjøth, KM Due, T Callréus, M Rosenzweig, ...
Journal of the American College of Cardiology 61 (22), 2264-2273, 2013
5332013
Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
TB Larsen, F Skjøth, PB Nielsen, JN Kjældgaard, GYH Lip
bmj 353, 2016
4212016
Indirect comparisons of new oral anticoagulant drugs for efficacy and safety when used for stroke prevention in atrial fibrillation
GYH Lip, TB Larsen, F Skjøth, LH Rasmussen
Journal of the American College of Cardiology 60 (8), 738-746, 2012
3732012
Classification of myocardial infarction: frequency and features of type 2 myocardial infarction
L Saaby, TS Poulsen, S Hosbond, TB Larsen, ACP Diederichsen, J Hallas, ...
The American journal of medicine 126 (9), 789-797, 2013
3112013
Effectiveness and safety of reduced dose non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
PB Nielsen, F Skjøth, M Søgaard, JN Kjældgaard, GYH Lip, TB Larsen
bmj 356, 2017
2832017
Maternal smoking, obesity, and risk of venous thromboembolism during pregnancy and the puerperium: a population-based nested case-control study
TB Larsen, HT Sørensen, M Gislum, SP Johnsen
Thrombosis research 120 (4), 505-509, 2007
2822007
Assessment of the CHA2DS2-VASc score in predicting ischemic stroke, thromboembolism, and death in patients with heart failure with and without atrial fibrillation
L Melgaard, A Gorst-Rasmussen, DA Lane, LH Rasmussen, TB Larsen, ...
Jama 314 (10), 1030-1038, 2015
2442015
Restarting anticoagulant treatment after intracranial hemorrhage in patients with atrial fibrillation and the impact on recurrent stroke, mortality, and bleeding: a nationwide …
PB Nielsen, TB Larsen, F Skjøth, A Gorst-Rasmussen, LH Rasmussen, ...
Circulation 132 (6), 517-525, 2015
2272015
Oral Anticoagulation, Aspirin, or No Therapy in Patients With Nonvalvular AF With 0 or 1 Stroke Risk Factor Based on the CHA2DS2-VASc Score
GYH Lip, F Skjøth, LH Rasmussen, TB Larsen
Journal of the American College of Cardiology 65 (14), 1385-1394, 2015
1782015
Temporal trends in incidence, prevalence, and mortality of atrial fibrillation in primary care
DA Lane, F Skjøth, GYH Lip, TB Larsen, D Kotecha
Journal of the American Heart Association 6 (5), e005155, 2017
1682017
Primary and secondary prevention with new oral anticoagulant drugs for stroke prevention in atrial fibrillation: indirect comparison analysis
LH Rasmussen, TB Larsen, T Graungaard, F Skjøth, GYH Lip
Bmj 345, 2012
1542012
Dabigatran adherence in atrial fibrillation patients during the first year after diagnosis: a nationwide cohort study
A Gorst‐Rasmussen, F Skjøth, TB Larsen, LH Rasmussen, GYH Lip, ...
Journal of Thrombosis and Haemostasis 13 (4), 495-504, 2015
1532015
Mortality rate in type 2 myocardial infarction: observations from an unselected hospital cohort
L Saaby, TS Poulsen, ACP Diederichsen, S Hosbond, TB Larsen, ...
The American journal of medicine 127 (4), 295-302, 2014
1532014
Major genetic susceptibility for venous thromboembolism in men: a study of Danish twins
TB Larsen, HT Sørensen, A Skytthe, SP Johnsen, JW Vaupel, ...
Epidemiology 14 (3), 328-332, 2003
1452003
Bleeding events among new starters and switchers to dabigatran compared with warfarin in atrial fibrillation
TB Larsen, A Gorst-Rasmussen, LH Rasmussen, F Skjøth, M Rosenzweig, ...
The American journal of medicine 127 (7), 650-656. e5, 2014
1412014
European heart rhythm association (EHRA)/European association of cardiovascular prevention and rehabilitation (EACPR) position paper on how to prevent atrial fibrillation …
B Gorenek, A Pelliccia, EJ Benjamin, G Boriani, HJ Crijns, RI Fogel, ...
European journal of preventive cardiology 24 (1), 4-40, 2017
1352017
Risk of stroke or systemic embolism in atrial fibrillation patients treated with warfarin: a systematic review and meta-analysis
IE Albertsen, LH Rasmussen, TF Overvad, T Graungaard, TB Larsen, ...
Stroke 44 (5), 1329-1336, 2013
1172013
Precision and accuracy of point‐of‐care testing coagulometers used for self‐testing and self‐management of oral anticoagulation therapy
TD Christensen, TB Larsen
Journal of Thrombosis and Haemostasis 10 (2), 251-260, 2012
1142012
Efficacy and safety of edoxaban in comparison with dabigatran, rivaroxaban and apixaban for stroke prevention in atrial fibrillation
F Skjøth, TB Larsen, LH Rasmussen, GYH Lip
Thrombosis and haemostasis 112 (05), 981-988, 2014
1132014
Systemet kan ikke foretage handlingen nu. Prøv igen senere.
Artikler 1–20